In the early stage of disease, SCFAs have protective effects in SLE by suppressing pathobiont (153)
My Clinical Perspective When patients ask about BPC-157 for mental health, I am direct: there is no human evidence supporting this use
Klicova M, Mullerova S, Rosendorf J, Klapstova A, Jirkovec R, Erben J, et al
Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, et al
[ 19 , 20 ] Its therapeutic effect could even be used in the treatment of severe conditions such as congestive heart failure (CHF)
The Pentose Phosphate Shunt Provides Reducing Equivalents For Reductive Biosynthesis And Maintaining An Intracellular Reducing Environment The activity of the oxidative phase of the pentose phosphate shunt is low in muscle, but high in liver, testis, adrenal cortex, and mammary gland, where NADPH is used in the synthesis of fatty acids or steroids, and in red blood cells, which are exposed to strongly oxidizing conditions as a result of their oxygen carrying function and use NADPH generated by the pentose phosphate shunt to counteract their oxidizing environment
